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ABSTRACT
Previously, we reported that glucose-deprived astrocytes are more vulnerable to the 
cytotoxicity of peroxynitrite, the reaction product of nitric oxide and superoxide anion. 
The augmented vulnerability of glucose-deprived astrocytes to peroxynitrite cytotoxicity 
was dependent on their proliferation rate. Inhibition of cell cycle progression has been 
shown to inhibit the apoptotic cell death occurring in cerebral ischemia-reperfusion. In 
the present study, we demonstrate that the increased death of glucose-deprived as-
trocytes by peroxynitrte was largely blocked by the cell cycle phase G2/M transition 
blocker etoposide. However, the cytoprotective effect of etoposide was not associated 
with its inhibition of cell cycle progression. Instead, etoposide effectively scavenged 
peroxynitrite. However, etoposide did not scavenge individual nitric oxide and super-
oxide anion and it did not prevent the hydrogen peroxide-induced cytotoxicity. The 
present results indicate that etoposide prevents the toxicity of peroxynitrite in astrocytes 
by directly scavenging peroxynitrite, not by inhibiting cell cycle progression.
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INTRODUCTION
    Immunostimulated  glial  cells  simultaneously  pro-
duce  nitric  oxide  (NO)  and  superoxide  anion  (O2
.−) 
via  expression  and  activation  of  inducible  nitric 
oxide  (iNOS)  (Simmons  and  Murphy,  1992).  NO 
and  O2
.−  rapidly  react  in  a  1：1  stoichiometry  to 
form  a  strong  oxidant  ONOO
−  (Beckman  et  al., 
1990).  ONOO
−  has  been  found  to  play  a  critical 
role  in  tissue  injury  and  appears  to  mediate  many 
of  the  cytotoxic  effects  (Beckman  et  al.,  1990). 
Previously,  we  showed  that  immunostimulated  as-
trocytes  themselves  became  highly  vulnerable  to 
glucose  deprivation  (GD)  (Choi  and  Kim,  1998; 
Choi  et  al.,  2001).  This  enhanced  vulnerability  was 
attributed  to  the  accumulation  of  ONOO
−  due  to 
the  disruption  of  intracellular  antioxidant  system 
(i.e.,  decreased  level  of  reduced  glutathione)  in 
glucose-deprived immunostimulated astrocytes (Choi 
and  Kim,  1998a;  1998b;  Choi  et  al.,  2000;  2001). 
Expectedly,  the  ONOO
−-releasing  reagent  3-mor-
pholinosydnonimine  (SIN-1)  also  augmented  the 
death  of  glucose-deprived  astrocytes.  Interestingly, 
we  further  found  that  the  augmented  death  of  im-
munostimulated  or  SIN-1-treated  astrocytes  under 
GD  was  dependent  on the  proliferative state  of  the 
astrocytes  (Choi  and  Kim,  1998b). 
    Activation  of  iNOS  was  reported  to  induce  cy-
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(Gu et al., 2000; Kotamraju et al., 2007). Apoptotic 
death of some cells can be blocked by coordinating 
the  progression  through  the  cell  cycle  and/or  by 
preventing  the  inappropriate  activation  of  cell  cycle 
signalling  pathways  (Park  et  al.,  1997;  Zhu  et  al., 
2007).  Because  proliferating  immunostimulated  as-
trocytes  are  much  more  vulnerable  to  GD,  it  is 
reasonable to think that the augmented death could 
be prevented by inhibition of cell cycle progression. 
    In  the present  study, therefore,  we  examined the 
possible  cytoprotective  effect  of  the  DNA  topo-
isomerase  II  inhibitor  etoposide  on  peroxynitrite 
toxicity  in  proliferating  astrocytes.  Interestingly,  the 
present  results  demonstrates  for  the  first  time  that 
etoposide  markedly  blocks  the  augmented  toxicity 
of  ONOO
−  in  SIN-1-treated/glucose-deprived  astro-
cytes  by  directly  scavenging  peroxynitrite,  not  by 
inhibiting  cell  cycle  progression.
MATERIALS  AND  METHODS
Astrocyte  cultures
    Astrocytes  were  cultured  from  the  prefrontal  cor-
tices of 2- to 5-day-old Sprague-Dawley rat pups as 
previously described (Choi and Kim, 1998a) In brief, 
cells were dissociated by mild trypsinization (10 min 
at  37
oC  with  Dulbecco's  modified  Eagle  medium 
(DMEM)  containing  0.1%  trypsin)  and  passed  th-
rough  a  sterile  nylon  sieve  (130μm  pore  size)  into 
DMEM  containing 10% heat-inactivated  fetal bovine 
serum (FBS). Cells were then plated (about 50,000 
cells/ml) onto poly-L-lysine (20μg/ml)-coated 75-cm
2 
culture  bottles  and  maintained  for  one  week  in 
DMEM/F12  supplemented  with  10%  FBS.  Astro-
cytes  were  then  trypsinized,  washed  and  re-plated 
in  the  growth  medium  onto  poly-L-lysine  (20μg/ 
ml)-coated  48-well  plates.  Cells  were  used  for  the 
experiments  5  to  7  days  later. 
Measurement  of  lactate  dehydrogenase
    Astrocytic  injury  and  death  was  assessed  by 
morphological examination of cells using phase-con-
trast  microscopy  and  quantified  by  measuring  the 
amount  of  lactate  dehydrogenase  (LDH)  released 
into  the  bathing  medium.  Activity  of  LDH  was 
measured  using  a  diagnostic  kit  (Sigma  Chemical 
Co.,  St.  Louis,  MO).  In  brief,  NADH  and  pyruvate 
(0.1 w/v %) were added and the samples incubated 
at  37
oC  for  30  min.  The  samples  then  were  in-
cubated  with  the  coloring  reagent  for  20  min.  The 
reaction  was  stopped  by  adding  0.4  N  NaOH,  and 
the  activity  (unit/ml)  of  LDH  in  each  sample  was 
calculated  from  the  standard  curve.  Total  LDH, 
which  corresponds  to  complete  astrocyte  death, 
was  measured in  sister  cultures  frozen  and  thawed 
after  the  experiments.  Cell  viability  was  expressed 
as  percentage  of  total  LDH. 
Determination  of  cell  cycle  distribution 
    Cells  were  washed  with  phosphate-buffered  sa-
line  (PBS),  trypsinized  and  pooled  with  the  cells 
collected from corresponding suspension at the end 
of  treatment.  After  washing  once  with  PBS,  cells 
were  resuspended  in  citrate  buffer  (250  mM  su-
crose,  40  mM  sodium  citrate,  pH  7.6).  Cells  were 
stained  for  30  min  in  ice-cold  DNA  staining/lysis 
buffer  (Mg
2＋  and  Ca
2＋-free  PBS  containing  10μg/ 
ml RNase, 20μg/ml propidium iodide, 0.5% NP-40, 
0.5  mM  EDTA,  pH  7.2).  Flow  cytometric  analysis 
was  performed  on  a  FACS  Caliber  (Becton  Dic-
kinson,  Mountain  View,  CA)  equipped  with  air- 
cooled 488 nm argon-ion laser. Using a CELLQuest 
software  (Becton  Dickinson,  Mountain  View,  CA), 
cell cycle distribution was analysed with a minimum 
of  10,000  cells.
Measurement  of  ONOO
−-induced  oxidation  of 
dihydrorhodamine  123
    The  ONOO
−-dependent  oxidation  of  dihydrorho-
damine  123  (DHR)  to  rhodamine  123  (RH)  was 
measured,  as  described  before  (Choi  et  al.,  2002). 
Briefly,  SIN-1  (200μM)  was  added  into  phosphate- 
buffered  saline  solution  (PBS)  containing  DHR  (10
μM)  in  the  absence  and  presence  of  etoposide. 
After a 10 min incubation at room temperature, the 
fluorescence  of  RH  was  measured  at  an  excitation 
wavelength  of  485  nm  and  emission  wavelength  of 
530  nm  (slit  widths  20  and  25  nm,  respectively) 
using  a  fluorescence  microplate  reader  (FL600, 
Bio-tek  Instruments,  Inc.,  Winooski,  VT).
Measurement  of  NO
    As previously described by us (Choi et al., 2002), 
the  amount  of  NO  was  measured  with  a  com-
mercially  available  Clark-type  electrode  (ISO-NO, 
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NO  is  oxidized  on  the  surface  of  a  prepolarized 
working  electrode,  permeable  only  for  gases  with 
low molecular weights, resulting in electrical current. 
This  current  (pA)  was  recorded  at  0.5  Hz  and 
converted  to  a  nM  concentration  of  NO  using  a 
calibration  curve  that  was  generated  daily.  NO  was 
released  from  200μM  S-nitroso-N-acetylpenicilla-
mine  (SNAP)  by  incubation  in  PBS  containing  4 
mM cysteine as  a reducing  agent and various con-
centrations  of  etoposide.  All  reagents  were  freshly 
prepared  before  use.  The  formation  of  NO  was 
quantified  from  the  initial  rate  of  release  using  the 
data acquisition system Duo18 (World Precision Ins-
truments,  Sarasota,  FL). 
Measurement  of  superoxide  anion 
    As previously described by us (Choi et al., 2002), 
the amount of superoxide anion was monitored with 
a Berthold LB9505 luminometer (Bad Wildbad, Ger-
many).  The  reaction  mixtures  contained  40  mU/ml 
xanthine  oxidase,  5μM  lucigenin,  and  various 
concentrations  of  etoposide  in  1  ml  of  air-saturated 
PBS  (pH  10).  The  superoxide-producing  reaction 
was  initiated  by  adding  xanthine  to  yield  a  final 
concentration  of  40μM.  All  reagents  were  freshly 
prepared in PBS. Chemiluminesence was measured 
at  1-min  intervals  for  10  min,  and  data  are  ex-
pressed  as  the  integrated  area  under  the  10-min 
curve.  Mean  blank  values  obtained  by  adding  300 
U/ml  SOD  were  subtracted  from  all  chemilumine-
scent  measurements.
Measurements  of  glutathione
    For  the  measurement  of  glutathione  (GSH),  as-
trocytes  were  washed  with  PBS,  and  then  in-
cubated  at  37
oC  for  10  min  with  50μM  mono-
chlorobimane.  Cells  were  washed  with  PBS  and 
then  lysed  with  PBS  containing  0.2%  Triton  X-100. 
The  fluorescence  of  the  monochlorobimane-GSH 
complex  was  measured  with  a  fluorescence  mi-
croplate  reader  (FL600,  Bio-tek  Instruments,  Inc., 
Winooski,  VT)  (excitation  wavelength  of  400  nm 
and  emission  wavelength  of  480  nm).  The  GSH 
content  of  the  samples  was  calculated  from  the 
standard  curve  prepared  from  GSH  standards 
incubated  in  the  presence  of  monochlorobimane 
and  glutathione  transferase  (Sigma  Chemical  Co., 
St.  Louis,  MO).  The  concentration  of  GSH  was 
expressed  as  nmol/mg  protein;  protein  content  was 
determined  using  the  bicinchoninic  acid  (Smith  et 
al.,  1985).
Measurement  of  hydrogen  peroxide
    Hydrogen  peroxide  (H2O2)  was  measured  spec-
trophotometrically  with  some  modifications  at  550 
nm at 37
oC by the peroxydase-catalysed conversion 
of  4-aminophenazone  to  a  pink-colored  substance. 
Measurement  was  started  after  adding  reagent  to 
solution  of  various  concentrations  of  etoposide  and 
H2O2. This reagent consisted of 10 parts of solution 
A  [4.2  mM  3,5-dichloro-2-hydroxybenzenesulphonic 
acid, dissolved in Mops buffer (50 mM Mops/50 mM 
KCl, pH 7.4)], 1 part of solution B (33 mM 4-amino-
phenazone)  and  2.3  units/ml  peroxydase  (final  ac-
tivity).
Statistical  analysis
    Data  are  expressed  as  the  mean±standard  error 
of  mean  (S.E.M.)  and  analysed  for  statistical  sig-
nificance  using  ANOVA  followed  by  Scheffe’s  test 
for  multiple  comparison.  A  p  value  ＜0.05  was 
considered  significant.
RESULTS
    As we previously reported (Choi and Kim, 1998a; 
Choi  et  al.,  2002a;  2002b),  SIN-1  potentiated  the 
LDH  release  (i.e.,  a  cell  death  marker)  in  glu-
cose-deprived  astrocytes  (Fig.  1).  Presence  of  eto-
poside (10μM) 16 h before (i.e., pre-treatment) and 
during  GD  (i.e.,  co-treatment)  completely  blocked 
the  potentiated  cell  death  (Fig.  1).  Similarly,  co- 
treatment  of  etoposide  alone  also  blocked  the  in-
creased  cell  death.  However,  FACS  analysis  using 
propidium  iodide  showed  that  co-treatment  of  eto-
poside  alone  did  not  arrest  the  cell  cycle  pro-
gression (Table 1). It implies that the cytoprotective 
effect of etoposide may not  caused by its inhibition 
of  cell  cycle  progression.
    In  brain,  one  of  many  well-known  actions  of 
astrocytes  is  to  produce  antioxidants,  which  sca-
venge  reactive  oxygen  species  and  buffer  oxidative 
stress. Astrocytes are known to be the main source 
of GSH which acts as a free radical scavenger and 
is  important  in  recycling  other  antioxidants  (Markar 
et  al.,  1994;  Ju  et  al.,  2000).  Thus,  astrocytes  ap-Etoposide  Reduces  ONOO
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Fig.  1.  Etoposide  inhibits  the  increased  death  in  astrocytes 
simultaneously  exposed  to  SIN-1  and  GD.  Astrocytes  were 
exposed  to  200μM  SIN-1  and/or  GD  with  or  without  pre-  and 
co-treatment,  or  just  co-treatment  of  etoposide.  LDH  levels  were 
determined  6  h  after  starting  the  GD.  Data  are  the  percent  of 
total LDH  and expressed as  the mean S.E.M. N=5.  ***p＜0.001, 
(two-way ANOVA followed by post-hoc Scheffe’s test) significantly 
different  from  the  untreated  group.
Table  1.  Changes  of  cell  cycle  distribution  by  etoposide. 
Astrocytes  were  exposed  to  200  mM  SIN-1  and/or  glucose 
deprivation  with  or  without  pre-(16  h)  and  co-treatment,  or  just 
co-treatment  of  etoposide
Treatments G0＋G1  (%) S  (%) G2＋M  (%)
Control 77.6±0.12 11.8±1.64 11.8±0.71
SIN-1 75.3±1.64 12.2±0.28 11.9±1.43
GD 78.9±0.11 11.3±1.34   9.9±0.93
SIN-1＋GD 74.1±0.59 12.7±0.96 12.5±1.55
SIN-1＋GD＋etoposide 81.4±2.98* 14.5±1.78   4.0±0.25**
  (pre-  and  co-treated)
SIN-1＋GD＋etoposide 76.8±2.90 12.1±1.43 10.9±1.85
  (co-treated)
N=7.  *p＜0.05,  **p＜0.001,  compared  with  the  group  simul-
taneously  treated  with  SIN-1  and  GD  in  the  absence  of 
etoposide.
Fig.  2.  Etoposide  inhibits  the  depletion  of  GSH  in  astrocytes 
simultaneously  exposed  to  SIN-1 a n d  G D .  ( A )  A s t r o c y t e s  w e r e  
exposed  to  200μM  SIN-1  and/or  GD  with  or  without  co-treat-
ment of etoposide. GSH levels were measured 1 h after starting 
GD.  Data  are  the  percent  of  total  LDH  and  expressed  as  the 
mean±S.E.M.  N=6.  ***p＜0.001,  (two-way  ANOVA  followed  by 
post-hoc  Scheffe’s  test)  significantly  different  from  the  untreated 
control  group.  (B)  Astrocytes  were  preincubated  with  100μM 
L-BSO  for  12  h  and  then  incubated  in  various  conditions.  GSH 
levels  were  measured  1  h  after  starting  GD  in  the  absence  and 
presence of 200μM SIN-1 and/or GD, and 10μM etoposide. (C) 
LDH  levels  were  measured  6  h  after  starting  of  GD  in  the 
absence  and  presence  of  200μM  SIN-1  and/or  GD,  and  10μM 
etoposide.  Data  are  the  percent  of  total  LDH  and  expressed  as 
the  mean±S.E.M.  N=9.  ***p＜0.001,  (two-way  ANOVA  followed 
by  post-hoc  Scheffe’s  test)  significantly  different  from  the  un-
treated  group.
pear  to  be  resistant  to  the  actions  of  the  strong 
oxidant  ONOO
−  (Barker  et  al.,  1996).  In  the 
present  study,  the  level  of  GSH  in  astrocytes  was 
synergistically  reduced  by  SIN-1  and  GD  (Fig.  2A). 
Co-treatment of etoposide prevented the synergistic 
decrease  of  GSH  (Fig.  2A).  Pretreatment  of  L- 
buthionine-S,R-sulfoximine  (BSO,  a  relatively  speci-
fic  inhibitor  of  GSH  biosynthesis)  for  16  h  depleted 
the  intracellular  GSH  (Fig.  2B).  Depletion  of  GSH 
itself  did  not  induce  the  cell  death,  but  increased 
the  release  of  LDH  in  astrocytes  exposed  to  SIN-1 
or SIN-1/ GD (Fig. 2C). Although etoposide did not 
block  the  GSH  depletion  by  BSO,  it  inhibited  the 
increased  peroxynitrite  toxicity  by  BSO  (Fig.  2C).
  The ONOO
− plays a critical role in the enhanced 
vulnerability  of  astrocytes  to  GD  (Ju  et  al.,  2000; 94 In-Young  Choi,  et  al.
Fig.  3.  Etoposide  scavenges  peroxynitrite,  but  not  NO  and 
superoxide  anion.  (A)  Peroxynitrite.  Cells  were  loaded  with  DHR 
and  then  the  fluorescence  intensities  were  measured  in  the 
presence  and  absence  of  SIN-1  and/or  etoposide.  Data  are 
expressed  as  fluorescence  intensities  (F.I.).  (B)  Nitric  oxide. N O  
was  generated  from  SNAP  in  the  presence  of  various  con-
centrations of etoposide (0.1 to  1  mM)  and 4  mM cysteine  as a 
reducing  agent.  The  formation  of  NO  was  quantified  from  the 
initial  rate  of  release  using  the  data  acquisition  system  Duo-18. 
(C) Superoxide anion. Production of O2
.− was initiated by adding 
xanthine  (final  concentration,  40μM)  to  the  reaction  mixtures 
described  in  the  Materials  and  Methods  section.  Superoxide 
anion was generated in the presence of various concentration of 
etoposide  (0.1 to  1  mM). All  data were normalized by the mean 
blank  values  obtained  by  adding  300  U/ml  SOD.  Results  were 
expressed  mean±S.E.M.  from  4  independent  experiments.  *p
＜0.05,  ***p＜0.001,  (two-way  ANOVA  followed  by  post-hoc 
Scheffe’s  test)  significantly  different  from  the  value  obtained i n  
the  absence  of  etoposide.
Fig.  4.  (A)  Etoposide  does  not  inhibit  the  depletion  of  GSH  in 
H2O2-treated  astrocytes.  Cells  were  exposed  to  H2O2 ( 1 0 0 μM) 
and  GD  in  the  absence  and  presence  of  etoposide.  GSH  levels 
were  measured  at  30  min  after  starting  GD  in  the  absence  and 
presence of 100μM H2O2. Data are expressed as the percent of 
untreated  astrocytes.  N=7.  (B)  Etoposide  does  not  prevent  the 
potentiated  H2O2  toxicity  in  glucose-deprived  astrocytes.  Astro-
cytes  were  exposed  to  H2O2  (100μM)  and  GD  in  the  absence 
and  presence  of  etoposide  for  2  h  and  then  incubated  in  the 
culture  medium.  LDH  levels  were  determined  6  h  after  starting 
GD.  Data  are  the  percent  of  total  LDH  and  expressed  as  the 
mean±S.E.M.  N=6.  (C)  Scavenging  effect  of  etoposide  on  H2O2. 
Various  concentrations  of  etoposide  were  incubated  with  H2O2 
(100μM) for 15 min at room temperature. The amounts of H2O2 
were  spectrophotometrically  measured  at  550  nm.  Data  are  ex-
pressed  as  the  percent  of  control.  N=5.  *p＜0.05,  ***p＜0.001, 
(two-way ANOVA followed by post-hoc Scheffe’s test) significantly 
different  from  the  value  obtained  in  the  absence  of  etoposide.
Choi et al., 2002a; 2002b). To quantify the ONOO
− 
scavenging  effect  of  etoposide,  we  used  the  di-
hydrorhodamine  123.  We  found  that  etoposide  ef-
fectively inhibited ONOO
− (SIN-1)-induced oxidation 
of  dihydrorhodamine  123  to  rhodamine  123  in  the 
presence of catalase (Fig. 3A). However, etoposide 
was little or less efficacious in scavenging NO (Fig. 
3B)  and  O2
.− ( F i g .  3 C ) .  
    Previously,  we  reported  that  GD  increased  the 
intracellular  concentration  of  H2O2  in  immunostimu-
lated  astrocytes,  leading  to  astroglial  cell  death 
(Choi  et  al.,  2004).  Our  present  study  showed  that 
both  GSH  depletion  and  death  in  astrocytes  si-
multaneously  exposed  to  GD  and  H2O2  were  not 
reversed by etoposide (Fig. 4A, B, respecively). We 
further  found  that  etoposide  did  not  effectively 
scavenge  H2O2 ( F i g .  4 C ) .Etoposide  Reduces  ONOO
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DISCUSSION
    Many  researchers  have  used  etoposide  for  ex-
perimentally  inducing  apoptosis  in  tumor  cells.  Stu-
dies  on  etoposide-induced  apoptotic  cell  death  in-
clude  the  processing  of  stabilized  cleavage  com-
plexes into frank DNA strand breaks, sensing of the 
DNA  damage,  leading  to  activation  of  stress-aso-
ciated  signaling  pathways  and  cell  cycle  arrest 
(Kubota et al., 1990; Ryan et al., 1991; Tsao et al., 
1992).  Etoposide  can  also  activate  a  pre-existing 
group  of  enzymes  and  enzyme  precursors,  typified 
by  the  cysteine-dependent  aspartate-directed  pro-
tease  (caspases)  (Henderson  et  al.,  2005).  The 
present  study,  however,  demonstrates  that  the 
anti-tumoric  DNA  topoisomerase  II  inhibitor  etopo-
side  can  reduce  the  peroxynitrite  toxicity  in  glu-
cose-deprived  astrocytes  by directly scavenging pe-
roxynitrite,  not  by  inhibiting  cell  cycle  progression. 
Furtherore,  etoposide  interacts  with  ONOO
− m o s t  
likely  due  to  the  high  reactivity  of  ONOO
−,  but  not 
with  other  products  NO,  O2
.−  and  H2O2.
    The  mammalian  cell  cycle  maintains  internal 
checkpoints  at  which  cells  are  arrested  when  pre-
vious  events have  not  been completed  in  response 
to  external  signals  (Hartwell  and  Weinert,  1989). 
The  cell  cycle  checkpoints  are  thought  to  exist  at 
the  G1/S  and  G2/M  transitions  (Agarwal  et  al., 
1995).  Etoposide  has  been  used  as  a  potent  and 
reversible  blocker  of  the  cell  cycle  that  appears  to 
act at the G2/M transition. Previously, we found that 
the  G1/S  transition  blockers  mimosine  and  ciclo-
pirox  also  blocked  the  peroxynitrite  toxicity.  Like 
etoposide,  mimosine  reduced  the  augmented  death 
of glucose-deprived immunostimulated astrocytes by 
directly  scavenging  peroxynitrite  rather  than  sup-
pressing  the  cell  cycle  progression  (Choi  et  al., 
2002a).  Unlike  mimosine,  however,  ciclopirox  block-
ed  the  peroxynitrite  toxicity  in  glucose-deprived 
SIN-1-treated  astrocytes  by  attenuating  peroxyni-
trite-induced  mitochondrial  dysfunction,  not  by  sca-
venging peroxynitrite (Choi et al., 2002b; Lee et al., 
2005).  Ciclopirox  neither  prevented  the  depletion  of 
reduced  glutathione  in  glucose-deprived  SIN-1-treat-
ed  astrocytes,  nor  scavenged  oxidants  such  as 
peroxynitrite,  nitric  oxide,  superoxide  anion,  hydro-
gen  peroxide  and  hydroxyl  radical  (Choi  et  al., 
2002b).  Because  of  those  various  mechanisms  of 
action,  therefore,  such  cell  cycle  inhibitors  should 
be  carefully  selected  for  the  studies  on  oxidative 
stress-related  cell  deaths.
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